Angiotensin‐Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID‐19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System

BACKGROUND: Previous reports suggest that the use of angiotensin‐converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) may upregulate angiotensin‐converting enzyme 2 receptors and increase severe acute respiratory syndrome coronavirus 2 infectivity. We evaluated the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Jaejin, Wei, Rong, Zhou, Hui, Luong, Tiffany Q., Gould, Michael K., Mefford, Matthew T., Harrison, Teresa N., Creekmur, Beth, Lee, Ming‐Sum, Sim, John J., Brettler, Jeffrey W., Martin, John P., Ong‐Su, Angeline L., Reynolds, Kristi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955437/
https://www.ncbi.nlm.nih.gov/pubmed/33307964
http://dx.doi.org/10.1161/JAHA.120.019669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955437/
https://www.ncbi.nlm.nih.gov/pubmed/33307964
http://dx.doi.org/10.1161/JAHA.120.019669

Ejemplares similares